Re: AAOMS Position Paper on Medication-Related Osteonecrosis of the Jaw-2022 Update

J Oral Maxillofac Surg. 2022 Nov;80(11):1723-1724. doi: 10.1016/j.joms.2022.07.149.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Bisphosphonate-Associated Osteonecrosis of the Jaw* / etiology
  • Bone Density Conservation Agents* / adverse effects
  • Diphosphonates / adverse effects
  • Humans
  • Osteonecrosis* / chemically induced

Substances

  • Bone Density Conservation Agents
  • Diphosphonates